Drug Profile
Finrozole
Alternative Names: MPV 2213ADLatest Information Update: 20 Dec 2005
Price :
$50
*
At a glance
- Originator Orion
- Class Antineoplastics; Benzonitrile; Small molecules; Triazoles
- Mechanism of Action Aromatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Urination disorders
Most Recent Events
- 20 Dec 2005 Discontinued - Phase-II for Urination disorders in Finland (PO)
- 16 May 2005 Hormos Medical has been acquired and merged into QuatRx Pharmaceuticals
- 15 Apr 2004 This compound is still in active development